HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumabRodrigo Sánchez-Bayona, Aleix Prat, Olga Martínez‐Sáez et al.|npj Breast Cancer|2025Cited by 6
Trastuzumab emtansine (T-DM1) plus capecitabine (X) in patients with HER2-positive MBC: MO28230 TRAX-HER2 phase 1 results.Karen A. Gelmon, Véronique Dièras, María Vidal et al.|Journal of Clinical Oncology|2014Cited by 4
Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast CancerEsther Sanfeliu, Aleix Prat, Sandra Cobo et al.|Clinical Cancer Research|2025Cited by 3
Figure 3 from Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast CancerEsther Sanfeliu, A. Prat, Anabel Martínez-Romero et al.|Unknown|2026Cited by 0
Figure 1 from Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast CancerEsther Sanfeliu, A. Prat, Anabel Martínez-Romero et al.|Unknown|2026Cited by 0